+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy



Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: Conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy



RadioTherapy and Oncology 117(2): 270-276



To compare late genitourinary (GU) and gastrointestinal (GI) toxicity following different prostate cancer treatment modalities. This study included 1084 consecutive prostate cancer patients treated with conventional radiotherapy, intensity-modulated radiotherapy (IMRT), permanent iodine-125 implantation (PI) alone, and PI combined with external beam radiotherapy (PI+EBRT). The effects of treatment- and patient-related factors on late grade ⩾ 2 (G2+) GU/GI toxicity risk were assessed. The median follow-up was 43 months (range, 12-97 months). Compared to the PI+EBRT, there was significantly less G2+ GU toxicity in the conventional radiotherapy (hazard ratio [HR] = 0.39; 95% CI, 0.20-0.77) and the IMRT (HR=0.45, 95% CI, 0.27-0.73). Compared to the PI+EBRT, there was significantly more G2+ GI toxicity in the IMRT (HR = 2.38; 95% CI, 1.16-4.87). In PI-related groups, prostate equivalent dose in 2 Gy fractions was a significant predictor of G2+ GU toxicity (p = 0.001), and the rectal volume receiving more than 100% of the prescribed dose was a significant predictor of G2+ GI toxicity (p = 0.001). The differences in the late G2+ GU/GI risk cannot be explained by the differences in treatment modalities themselves, but by the total radiation dose to the GU/GI tract, which had a causal role in the development of late G2+ GU/GI toxicity across all treatment modality groups.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057468336

Download citation: RISBibTeXText

PMID: 26318662

DOI: 10.1016/j.radonc.2015.08.019


Related references

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1T2 prostate cancer. International Journal of Radiation Oncology*biology*physics 58(1): 25-33, 2004

Radical prostatectomy, external beam radiotherapy 72 Gy, external beam radiotherapy gtoreq 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. International Journal of Radiation Oncology Biology Physics 54(2 Suppl.): 38-39, 2002

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. International Journal of Radiation Oncology, Biology, Physics 58(1): 25-33, 2003

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. International Journal of Radiation Oncology*biology*physics 54(2-Supp-S): 38-39, 2002

In regard to Kupelian et al.: Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seed/external beam radiotherapy for stage T1-T2 prostate cancer (Int J Radiat Oncol Biol Phys 2004;58:25-33). International Journal of Radiation Oncology, Biology, Physics 61(2): 631-2; Author Reply 632, 2005

Quality of life assessment 3 year after hypofractionated external beam radiotherapy for localized prostate cancer Comparison with 3D conformal radiotherapy, and permanent seed implantation. International Journal of Radiation Oncology Biology Physics 54(2 Suppl.): 186, 2002

Quality of life assessment 3 year after hypofractionated external beam radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: comparison with 3D conformal radiotherapy, and permanent seed implantation. International Journal of Radiation Oncology*biology*physics 54(2-Supp-S): 186-0, 2002

Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer. Zhonghua Wei Chang Wai Ke Za Zhi 21(12): 1414-1420, 2018

Adjuvant radiotherapy for gastric cancer: A dosimetric comparison of 3-dimensional conformal radiotherapy, tomotherapy and conventional intensity modulated radiotherapy treatment plans. Medical Dosimetry 35(2): 115-121, 2010

Small bowel toxicity in pelvic radiotherapy for postoperative gynecological cancer: comparison between conformal radiotherapy and intensity modulated radiotherapy. Asia-Pacific Journal of Clinical Oncology 9(3): 280-284, 2014

New radiotherapy technologies for meningiomas: 3D conformal radiotherapy? Radiosurgery? Stereotactic radiotherapy? Intensity-modulated radiotherapy? Proton beam radiotherapy? Spot scanning proton radiation therapy... or nothing at all?. RadioTherapy and Oncology 71(3): 247-249, 2004

Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy. Physics in Medicine and Biology 60(3): 1237-1257, 2016

Chest wall desmoid tumours treated with definitive radiotherapy: a plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy. Radiation Oncology 11: 34, 2016

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer. Prostate International 4(1): 25-29, 2016

Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma. RadioTherapy and Oncology 93(1): 125-130, 2010